Health Data Platform H1 Secures $40M from CVS Health Ventures

Healthcare data provider H1 secured $40 million in a new funding round led by CVS Health Ventures, a transaction highlighting that certain data-centric platforms remain attractive targets for corporate venture capital despite a broader slowdown in traditional SaaS investment.

The nine-year-old company, which operates a platform tracking detailed information on physicians globally, sells access to that data to pharmaceutical companies, hospital systems, and health insurers. While many pre-AI era software startups are facing challenging fundraising environments, H1's core value proposition—acting as a primary data provider rather than a replicable workflow tool—appears to have insulated it from current market headwinds.

Why this matters

The transaction indicates a strategic shift where major healthcare incumbents, such as the venture arm of CVS Health, are deploying capital into foundational data architecture rather than consumer-facing applications or generic workflow software. H1 reported turning cash flow and EBITDA profitable last year and is forecasting over 40% growth this year, suggesting the company did not strictly need the capital for survival but chose to accept the strategic partnership with a major industry player.

H1 was previously valued at $750 million during a $100 million funding round led by Altimeter Capital in November 2021. The company has since focused on achieving profitability and executing strategic acquisitions of smaller competitors, aligning with broader post-2021 mandates for startup efficiency.

What to watch next

In the near term, market observers will monitor whether H1 utilizes the new $40 million injection for further strategic acquisitions or to expand its proprietary data sets. Furthermore, H1's management has indicated their proprietary physician data may become increasingly valuable to AI model developers, positioning the company to potentially capture revenue from both traditional healthcare entities and emerging artificial intelligence platforms seeking verified medical professional data.